Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)

This study has been completed.
Sponsor:
Collaborators:
Aaron Diamond AIDS Research Center
Merck Sharp & Dohme Corp.
Pfizer
Information provided by (Responsible Party):
Rockefeller University
ClinicalTrials.gov Identifier:
NCT00525733
First received: September 5, 2007
Last updated: November 15, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)